- 专利标题： METHODS AND COMPOSITION FOR A BINDING MOLECULE TARGETING CANCER CELLS EXPRESSING SSX2 PEPTIDE 41-49 IN HLA-A*0201 CONTEXT
-
申请号： US17552862申请日： 2021-12-16
-
公开(公告)号： US20220185909A1公开(公告)日： 2022-06-16
- 发明人: Eric YVON , Catherine BOLLARD , Stacey VAN PELT , Scott RASKIN , Gerhard HELD , Christine STURM , Michael PFREUNDSCHUH
- 申请人： CHILDREN'S NATIONAL MEDICAL CENTER , THE GEORGE WASHINGTON UNIVERSITY , UNIVERSITAT DES SAARLANDES
- 申请人地址： US DC Washington; US DC Washington; DE Saarbrucken
- 专利权人： CHILDREN'S NATIONAL MEDICAL CENTER,THE GEORGE WASHINGTON UNIVERSITY,UNIVERSITAT DES SAARLANDES
- 当前专利权人： CHILDREN'S NATIONAL MEDICAL CENTER,THE GEORGE WASHINGTON UNIVERSITY,UNIVERSITAT DES SAARLANDES
- 当前专利权人地址： US DC Washington; US DC Washington; DE Saarbrucken
- 主分类号： C07K16/30
- IPC分类号： C07K16/30 ; C07K14/47
摘要：
Disclosed are Synovial Sarcoma X breakpoint 2 binding molecules and methods for their use in the detection and treatment of cancer.